Terms: = Sarcomas AND Ki-67 AND Clinical Outcome
23 results:
1. TOP2A Expression in Pheochromocytoma and Abdominal Paraganglioma: a Marker of Poor clinical outcome?
Solhusløkk Höse K; Stenman A; Svahn F; Larsson C; Juhlin CC
Endocr Pathol; 2023 Mar; 34(1):129-141. PubMed ID: 36656469
[TBL] [Abstract] [Full Text] [Related]
2. Extraskeletal myxoid chondrosarcoma: p53 and ki-67 offer prognostic value for clinical outcome - an immunohistochemical and molecular analysis of 31 cases.
Giner F; López-Guerrero JA; Machado I; Rubio-Martínez LA; Espino M; Navarro S; Agra-Pujol C; Ferrández A; Llombart-Bosch A
Virchows Arch; 2023 Feb; 482(2):407-417. PubMed ID: 36376703
[TBL] [Abstract] [Full Text] [Related]
3. Expression of cancer stem cell markers in breast phyllodes tumor.
Kim SI; Koo JS
Cancer Biomark; 2020; 29(2):235-243. PubMed ID: 32675396
[TBL] [Abstract] [Full Text] [Related]
4. Whorling cellular perineurioma: A previously undescribed variant closely mimicking monophasic fibrous synovial sarcoma.
Michal M; Kazakov DV; Agaimy A; Hosova M; Michalova K; Grossmann P; Steiner P; Skenderi F; Vranic S; Michal M
Ann Diagn Pathol; 2017 Apr; 27():74-78. PubMed ID: 28325366
[TBL] [Abstract] [Full Text] [Related]
5. Primary leiomyosarcoma of the spine: A case report and literature review.
Yang Y; Ma L; Li L; Liu H
Medicine (Baltimore); 2017 Mar; 96(9):e6227. PubMed ID: 28248883
[TBL] [Abstract] [Full Text] [Related]
6. Prognostic significance of miR-34a in Ewing sarcoma is associated with cyclin D1 and ki-67 expression.
Marino MT; Grilli A; Baricordi C; Manara MC; Ventura S; Pinca RS; Bellenghi M; Calvaruso M; Mattia G; Donati D; Tripodo C; Picci P; Ferrari S; Scotlandi K
Ann Oncol; 2014 Oct; 25(10):2080-2086. PubMed ID: 25015333
[TBL] [Abstract] [Full Text] [Related]
7. [Clinicopathologic features and prognostic factors of malignant phyllodes tumors].
Jia C; Mei F; Zheng J; You JF; Liu JY
Zhonghua Bing Li Xue Za Zhi; 2013 Nov; 42(11):729-34. PubMed ID: 24447548
[TBL] [Abstract] [Full Text] [Related]
8. Poorly differentiated synovial sarcoma is associated with high expression of enhancer of zeste homologue 2 (EZH2).
Changchien YC; Tátrai P; Papp G; Sápi J; Fónyad L; Szendrői M; Pápai Z; Sápi Z
J Transl Med; 2012 Oct; 10():216. PubMed ID: 23110793
[TBL] [Abstract] [Full Text] [Related]
9. Clinicopathological and immunohistochemical characteristics of esophageal carcinosarcoma.
Sano A; Sakurai S; Kato H; Sakai M; Tanaka N; Inose T; Saito K; Sohda M; Nakajima M; Sakamoto K; Sano T; Hosoya Y; Enomoto T; Kanda T; Ajioka Y; Oyama T; Kuwano H
Anticancer Res; 2009 Aug; 29(8):3375-80. PubMed ID: 19661359
[TBL] [Abstract] [Full Text] [Related]
10. Diagnostic relevance of the immunohistochemical detection of growth factors in benign and malignant cartilaginous tumors.
Falcone G; Rossi ED; Maccauro G; de Santis V; Rosa MA; Capelli A; Fadda G
Appl Immunohistochem Mol Morphol; 2006 Sep; 14(3):334-40. PubMed ID: 16932026
[TBL] [Abstract] [Full Text] [Related]
11. Prognostic significance of grading (MIB-1 system) in patients with myxoid liposarcoma.
Tateishi U; Hasegawa T; Beppu Y; Kawai A; Moriyama N
J Clin Pathol; 2003 Aug; 56(8):579-82. PubMed ID: 12890805
[TBL] [Abstract] [Full Text] [Related]
12. Oncoproteins and proliferation markers in synovial sarcomas: a clinicopathologic study of 19 cases.
Barbashina V; Benevenia J; Aviv H; Tsai J; Patterson F; Aisner S; Cohen S; Fernandes H; Skurnick J; Hameed M
J Cancer Res Clin Oncol; 2002 Nov; 128(11):610-6. PubMed ID: 12458341
[TBL] [Abstract] [Full Text] [Related]
13. Expression of p53 gene product and cell proliferation marker ki-67 in Ewing's sarcoma: correlation with clinical outcome.
Amir G; Issakov J; Meller I; Sucher E; Peyser A; Cohen IJ; Yaniv I; Ben Arush MW; Tavori U; Kollender Y; Ron N; Peylan-Ramu N
Hum Pathol; 2002 Feb; 33(2):170-4. PubMed ID: 11957141
[TBL] [Abstract] [Full Text] [Related]
14. p53 and ki-67 expression as prognostic factors in cystosarcoma phyllodes.
Erhan Y; Zekioglu O; Ersoy O; Tugan D; Aydede H; Sakarya A; Kapkaç M; Ozdemir N; Ozbal O; Erhan Y
Breast J; 2002; 8(1):38-44. PubMed ID: 11856160
[TBL] [Abstract] [Full Text] [Related]
15. High ki-67 proliferative index predicts disease specific survival in patients with high-risk soft tissue sarcomas.
Hoos A; Stojadinovic A; Mastorides S; Urist MJ; Polsky D; Di Como CJ; Brennan MF; Cordon-Cardo C
Cancer; 2001 Aug; 92(4):869-74. PubMed ID: 11550160
[TBL] [Abstract] [Full Text] [Related]
16. Validation of tissue microarrays for immunohistochemical profiling of cancer specimens using the example of human fibroblastic tumors.
Hoos A; Urist MJ; Stojadinovic A; Mastorides S; Dudas ME; Leung DH; Kuo D; Brennan MF; Lewis JJ; Cordon-Cardo C
Am J Pathol; 2001 Apr; 158(4):1245-51. PubMed ID: 11290542
[TBL] [Abstract] [Full Text] [Related]
17. Synovial sarcoma. A Scandinavian Sarcoma Group project.
Skytting B
Acta Orthop Scand Suppl; 2000 Apr; 291():1-28. PubMed ID: 10862210
[TBL] [Abstract] [Full Text] [Related]
18. Prognostic significance of nuclear accumulation of c-myc and mdm2 proteins in synovial sarcoma of the extremities.
Shen J; Scotlandi K; Baldini N; Manara MC; Benini S; Cerisano V; Picci P; Serra M
Oncology; 2000 Apr; 58(3):253-60. PubMed ID: 10765129
[TBL] [Abstract] [Full Text] [Related]
19. Altered expression of p53 and its regulated proteins in phyllodes tumours of the breast.
Kuenen-Boumeester V; Henzen-Logmans SC; Timmermans MM; van Staveren IL; van Geel A; Peeterse HJ; Bonnema J; Berns EM
J Pathol; 1999 Oct; 189(2):169-75. PubMed ID: 10547570
[TBL] [Abstract] [Full Text] [Related]
20. Hyperthermic isolated limb perfusion with tumor necrosis factor-alpha and melphalan in patients with locally advanced soft tissue sarcomas: treatment response and clinical outcome related to changes in proliferation and apoptosis.
Plaat BE; Molenaar WM; Mastik MF; Koudstaal J; van den Berg E; Koops HS; Hoekstra HJ
Clin Cancer Res; 1999 Jul; 5(7):1650-7. PubMed ID: 10430064
[TBL] [Abstract] [Full Text] [Related]
[Next]
